A study in the January 2026 issue of The Journal of Bone and Joint Surgery found that AxioMed’s viscoelastic disc had lower wear rates compared to ball-and-socket artificial discs.
Four things to know:
1. AxioMed’s Freedom lumbar disc underwent 30 million cycles of MTS servohydraulic testing to simulate about 240 years of human life. It didn’t have any mechanical failure, according to a Jan. 30 news release from KIC Ventures.
2. Comparative data was measured for the Charite disc and Prodisc L from the FDA’s Summary of Safety and Effectiveness Data. AxioMed’s disc had a mean wear rate of 1.7 mg/MC compared to 5.7 mg/MC for the prodisc L.
3. The AxioMed disc also produced significantly fewer particles that are biologically “quiet.”
4. The study concluded: “The AxioMed 1-piece VTDR device demonstrated a lower wear rate and larger, less biologically reactive, particles compared with articulating TDRs, suggesting a reduced risk of osteolysis and longer implant lifespan. No mechanical failures were observed, even after each 10-million-cycle interval, which simulates approximately 80 years of lumbar-bending motions. This study focused on particle size; further work is warranted to characterize composition and particle burden.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
